ask="1.8500"
ask_size="700"
average_daily_volume="155520"
bid="1.3800"
bid_size="1000"
book_value="1.0670"
change="+0.0301"
change_from_200_day_moving_average="-0.3476"
change_from_50_day_moving_average="0.0252"
change_from_52_week_high="-4.1979"
change_From_52_week_low="0.6101"
change_in_percent="+1.9545%"
close="1.5701"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.0060"
ebitda="-16.58M"
eps_estimate_current_year="-2.9100"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-1.3700"
ex_dividend_date="N/A"
float_shares="5083000"
high="1.6000"
high_52_weeks="5.7680"
last_trade_date="3/1/2017"
last_trade_price="1.5701"
last_trade_size="100"
last_trade_time="3:50pm"
low="1.5133"
low_52_weeks="0.9600"
market_capitalization="18.35M"
moving_average_200_day="1.9177"
moving_average_50_day="1.5449"
name="PhaseRx
Inc."
notes="N/A"
one_year_target_price="10.0000"
open="1.6000"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-18.1263%"
percent_change_from_50_day_moving_average="+1.6285%"
percent_change_from_52_week_high="-72.7791%"
percent_change_from_52_week_low="+63.5521%"
previous_close="1.5400"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.4433"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="11690000"
short_ratio="0.2100"
stock_exchange="NCM"
symbol="PZRX"
volume="9613"
weeks_range_52="0.9600 - 5.7680"
